ClinicalTrials.govpublic full text
A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With EGFR-Positive Advanced Non-Small Cell Lung Cancer
carcinoma, non-small-cell lung, mrg003, antibody drug conjugate (adc), egfr, non-small cell lung cancer (nsclc), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 876485
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.